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Abstract: Chronic kidney disease (CKD) has recently been recognized as a risk factor for 
cardiovascular disease, while the mechanism by which CKD develops remained to be clariﬁ  ed. 
In the present study, we conducted a cross-sectional, community-based study to identify the 
factor(s) associated with CKD. We examined 1978 local residents of the Kiyotake area of Japan 
(697 males and 1281 females; age, 60.8 ± 11.0 years; mean ± SD), who had an annual health 
check-up. Diagnosis of CKD was made based on dipstick proteinuria of +1 or higher, or on a 
reduced glomerular ﬁ  ltration rate (GFR) estimated from serum creatinine level to less than 60 
ml/min/1.73 m2. Body mass index (BMI) and prevalence of obesity in the residents with CKD 
were found to be higher than in those without CKD in both genders. When compared with the 
residents without CKD, the ratios of residents taking antihypertensive medicines were higher in 
both genders, and the blood pressure and fasting blood glucose levels of males and the triglyceride 
level of females were elevated in those with CKD. These parameters or factors were found to 
be signiﬁ  cant for CKD by a univariate logistic analysis. We further analyzed the data with a 
multivariate logistic method using age, BMI, antihypertensive and antidyslipidemic medicines, 
blood pressure, serum lipid and glucose as independent covariates, and found that BMI was a 
signiﬁ  cant parameter independently correlated with CKD in both genders. Thus, increased BMI 
is associated with CKD independently of blood pressure, serum lipid and glucose levels in the 
general population.
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Introduction
Chronic kidney disease (CKD) is deﬁ  ned as either structural and/or functional 
abnormality of the kidney or reduced glomerular ﬁ  ltration rate (GFR) to a level less 
than 60 ml/min/1.73 m2.1,2 CKD has recently been recognized as a challenging public 
health issue not only because numbers of patients with end-stage renal disease (ESRD) 
are steadily increasing in developed countries including Japan, but also because recent 
epidemiological studies showed that CKD is a signiﬁ  cant risk factor for cardiovascular 
disease.3–5 For example, the number of ESRD patients in Japan is currently greater than 
250,000, and this has become an economic burden for the health care system.6 On the 
other hand, it was shown in a Japanese community by a prospective study that ischemic 
heart disease and cerebral infarction are more frequent in the male and female residents 
with CKD, respectively, than in those without it.5 In order to prevent or reduce devel-
opment of CKD at a community level, it is essential to identify or specify the cause(s) 
of CKD. Because GFR is reduced by aging, CKD is more frequent in elderly people 
than in younger ones. Besides aging, possible factors involved in the development of 
CKD are hypertension, impaired glucose tolerance or diabetes mellitus, dyslipidemia 
and obesity,7–14 but the detailed mechanism(s) remains to be clariﬁ  ed. In the present Vascular Health and Risk Management 2009:5 316
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study, we carried out a community-based, cross-sectional 
study of the local residents of the Kiyotake area in an attempt 
to identify the factor(s) associated with CKD.
Materials and methods
Study subjects and protocol
In this study, we examined local residents in the Kiyotake area, 
Miyazaki, Japan, who had an annual health check-up from 
September to October of 2006 responding to the recommenda-
tion made by the municipal government for those of 40 years 
or older. Upon visiting the community center of Kiyotake 
town, medical history of the subjects was taken by nurses and 
conﬁ  rmed by physicians, and blood pressure was measured 
with an oscillometric automatic device (BP-103iII; Colin Japan 
Ltd, Tokyo, Japan) in a sitting position by experienced nurses. 
Urine was collected and blood was drawn from an antecubital 
vein after overnight fast. Serum lipid and glucose levels were 
measured by the automatic analyzer (Olympus AU2700; 
Olympus, Tokyo, Japan) with serum creatinine levels deter-
mined by the enzymatic method. GFRs were calculated with 
the formula of 0.741 × 175 × Age−0.203 × serum creatinine−1.154 
(further multiplied by 0.742 for females), the Modiﬁ  cation of 
Diet in Renal Disease (MDRD) Study equation further modiﬁ  ed 
for Japanese people by the Japanese Society of Nephrology.15,16 
Residents were judged to have CKD when estimated GFR 
(eGFR)  60 ml/min/1.73 m2 or spot urine protein determined 
by dipstick measurement   + 1 (30 mg/dl). Obesity was deﬁ  ned 
with body mass index (BMI) of 25 kg/m2 or larger, according 
to the criteria of the Japan Society for the Study of Obesity.17
In this health check-up program, 2085 residents (761 males, 
63.1 ± 10.7 years; 1324 females, 59.8 ± 10.9 years; mean ± SD) 
visited during the time period mentioned above. From those 
subjects, not to analyze CKD closely related with diabetic 
nephropathy, we excluded residents with fasting blood glu-
cose levels of 126 mg/dl or higher (n = 80), or those who 
were taking glucose−lowering agents or had been diagnosed 
as having diabetes mellitus by any physician (n = 55). In addi-
tion, two male residents who had renal failure with eGFR less 
than 15 ml/min/1.73 m2 were excluded from the analysis. As 
a result, we ﬁ  nally analyzed the data from 1978 local residents 
(697 males, 63.0 ± 10.8 years; 1281 females, 59.6 ± 10.9 years). 
This study was approved by the Review Committee of Coopera-
tive and Commissioned Research and the Ethics Committee of 
University of Miyazaki Faculty of Medicine.
Statistical analysis
All the data were analyzed with SPSS software version 
17.0 (SPSS Inc., Chicago, IL). Comparisons of two groups 
were assessed by unpaired t-test or Chi-squared test, 
and the relationship between BMI and eGFR was evaluated 
by linear regression analysis. The data were further examined 
by univariate and then multivariate logistic methods to extract 
signiﬁ  cant, independent factors for CKD. All the data were 
expressed as means ± SD and a P value less than 0.05 was 
considered to be signiﬁ  cant.
Results
Table 1 shows the basal proﬁ  les of the male and female resi-
dents examined in this study. As shown, 22.8% of male and 
15.7% of female residents were found to have CKD, diagnosis 
of which was made by estimated GFR  60 ml/min/1.73 m2 in 
330 residents, by dipstick proteinuria   + 1 in 16 or by both 
in 14. Expectedly, the mean ages in the male and female resi-
dents with CKD were higher (P   0.01) than in those without 
CKD. When compared with the residents without CKD, BMI 
of both genders was slightly, but signiﬁ  cantly higher in those 
with CKD, resulting in signiﬁ  cantly increased prevalence of 
obesity. When analyzed by linear regression analysis, BMI 
was found to be signiﬁ  cantly correlated with eGFR in both 
genders (Figure 1). Current smoker ratio in the male CKD 
residents was lower than in the controls (P   0.05), while no 
difference was noted in the female residents. Both the systolic 
and diastolic blood pressure levels in the CKD subjects were 
higher than in the controls in male (P   0.01), but this was not 
the case for female. Meanwhile, ratios of subjects who were 
taking antihypertensive medicines in the CKD residents were 
signiﬁ  cantly higher than in those without CKD in both genders. 
The fasting blood glucose (FBG) levels of the males (P   0.05) 
and the triglyceride level of the females (P   0.01) with CKD 
were found to be higher, compared with those without it, while 
there were no signiﬁ  cant differences in ratio of the residents 
taking antidyslipidemic medicines. The number of residents 
who had a family history of cardiovascular diseases (CVD) 
was slightly higher in the residents with CKD in both genders, 
but the differences were not statistically signiﬁ  cant.
The results of univariate and multivariate logistic analyses 
are shown in Table 2 for males and in Table 3 for females. 
In the univariate analyses, age, BMI and antihypertensive 
medication were found to be signiﬁ  cant for CKD in both 
genders, and in addition, judged to be signiﬁ  cant were 
smoking, blood pressure and FBG for males and triglyceride 
for females. Because differences were noted in smoking, 
blood pressure, antihypertensive medication, triglyceride, 
and FBG between those with and without CKD, we next 
analyzed the data by means of a multivariate logistic analysis 
using CKD as a dependent variable and the parameters listed Vascular Health and Risk Management 2009:5 317
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in Tables 2 and 3 as independent covariates. As shown, 
smoking, blood pressure, antihypertensive medication, and 
FBG became insigniﬁ  cant, but BMI was found to be inde-
pendently signiﬁ  cant for CKD as well as age in both genders, 
and in females, triglyceride was a signiﬁ  cant factor.
Discussion
Chronic kidney disease (CKD) has recently been recognized 
not only as a risk factor of ESRD, but also of CVD which 
is a leading cause of death in developed countries.1,2,6 An 
interventional approach is necessary to prevent development 
of CKD at a community level, while the detailed mechanisms 
by which CKD develops remained to be speciﬁ  ed. In the pres-
ent study, we conducted this cross-sectional, observational 
study in the Kiyotake area, a Japanese community, and found 
that an increase in BMI is a signiﬁ  cant factor independently 
associated with CKD.
Age is an important factor closely related with CKD 
because GFR is reduced by aging, while a number of factors 
have been shown to be associated with CKD besides aging. 
These are hypertension, impaired glucose tolerance or dia-
betes mellitus, dyslipidemia, obesity, and smoking.7–14 In the 
present study, to avoid including CKD secondary to diabetic 
nephropathy, we excluded subjects with diabetes mellitus or 
with a fasting blood glucose level of 126 mg/dl or higher. As 
shown in the basal proﬁ  les of the residents with CKD, the 
blood pressure and FBG level of males and the triglyceride 
level of females were signiﬁ  cantly elevated, and the ratios 
of subjects taking antihypertensive medicine were higher in 
both genders, compared with those without CKD. Indeed, 
these parameters were signiﬁ  cant for CKD in the univariate 
logistic analysis. But in the multivariate analysis, they were 
judged to be insigniﬁ  cant except for triglyceride in females, 
while BMI, as well as age, was extracted as an independently 
signiﬁ  cant factor for CKD.
Hypertension has been clearly shown to be an important 
risk factor for future reduction in GFR and development of 
ESRD,7,8 but we found no signiﬁ  cant association between 
CKD and blood pressure in the present study despite the 
fact that both the systolic and diastolic blood pressure levels 
were higher in the males with CKD than without CKD. The 
lack of association can be attributed to the close relation-
ship between age and blood pressure levels, because blood 
pressure was judged to be signiﬁ  cant for CKD by univariate 
analysis, but became insigniﬁ  cant when adjusted with the 
other parameters including age (Table 2). Obesity has also 
been recognized as a factor related with CKD, but there 
has been no clear answer to an important question: what is 
the underlying mechanism of CKD developing in associa-
tion with increased BMI. Assumed to be involved are the 
activated renin–angiotensin system, increased sympathetic 
nerve activity, insulin-resistance or hyperinsulinemia and 
dyslipidemia.7–14,18 It was reported that impaired glucose 
tolerance (IGT) is associated with development of CKD.11,19 
Table 1 Basal proﬁ  les of male and female residents with or without CKD
CKD Male Female
(−)( +)( −)( +)
n 538 159 1080 201
Age (year) 61.8 ± 10.8 66.9 ± 9.8b 58.7 ± 10.4 64.7 ± 12.1b
BMI (Kg/m2) 20.0 ± 2.8 23.9 ± 2.8b 21.9 ± 3.1 22.5 ± 3.2a
Obesity (%) 23.2 32.1a 13.5 18.9a
Smoking (%) 28.3 18.9a 3.1 2.0
SBP (mmHg) 128 ± 18 135 ± 18b 122 ± 18 125 ± 17
DBP (mmHg) 79 ± 10 82 ± 10b 73 ± 10 73 ± 9
Antihypertensive medicine (%) 17.3 27.0b 12.1 21.4b
Total cholesterol (mg/dl) 199 ± 32 201 ± 31 214 ± 35 215 ± 36
HDL-cholesterol (mg/dl) 56 ± 13 54 ± 12 64 ± 14 62 ± 16
Triglyceride (mg/dl) 112 ± 80 123 ± 83 91 ± 45 101 ± 56a
Antidyslipidemic medicine (%) 2.2 2.5 7.5 7.5
FBG (mg/dl) 94.5 ± 9.1 96.5 ± 9.8a 91.4 ± 8.5 91.7 ± 7.9
EGFR (ml/min/1.73m2) 72 ± 10 54 ± 8b 75 ± 12 53 ± 8b
Family history of CVD (%) 20.3 27.7 23.4 28.4
Abbreviations: BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; HDL, high-density lipoprotein; FBG, fasting blood glucose; eGFR, estimated GFR; 
CVD, cardiovascular disease. 
Deﬁ  nition of obesity, BMI  = 25.0 Kg/m2; Mean+/−SD; aP   0.05, bP   0.01, vs male or female residents without CKD.Vascular Health and Risk Management 2009:5 318
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Figure 1 Linear regression analyses of relationship between eGFR and BMI in the male a) and female b) residents. Regression lines and 95% conﬁ  dence limits are shown in 
each graph.
Abbreviations: BMI, body mass index; eGFR, estimated glomerular ﬁ  ltration rate.Vascular Health and Risk Management 2009:5 319
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Table 3 Identiﬁ  cation of factor(s) associated with CKD by univariate and multivariate logistic analyses in female subjects
Female Univariate Multivariate
Parameters Odds ratio 95% CI Odds ratio 95% CI
Age (year) 1.054b 1.038–1.069 1.062b 1.043–1.081
BMI (Kg/m2) 1.056a 1.008–1.107 1.071a 1.013–1.132
Smokingc 0.625 0.219–1.780 0.795 0.272–2.321
SBP (mmHg) 1.007 0.999–1.016 0.991 0.976–1.006
DBP (mmHg) 1.001 0.986–1.016 0.995 0.972–1.020
Antihypertensive medicinec 1.972b 1.344–2.893 1.312 0.852–2.021
Total cholesterol (mg/dl) 1.002 0.997–1.006 1.000 0.994–1.005
HDL-cholesterol (mg/dl) 0.993 0.982–1.003 1.008 0.994–1.022
Triglyceride (mg/dl) 1.004b 1.001–1.007 1.004a 1.000–1.008
Antidyslipidemic medicinec 0.994 0.560–1.762 0.620 0.341–1.128
FBG (mg/dl) 1.004 0.986–1.022 0.981 0.961–1.001
Abbreviations: BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; HDL, high-density lipoprotein; FBG, fasting blood glucose. 
Notes: aP   0.05, bP   0.01; cSmoking, cAntihypertensive medicine, cAntidyslipidemic medicine (no = 1 and yes = 2).
The residents with diabetes mellitus or with a fasting blood 
glucose level of 126 mg/dl or higher were excluded, while 
neither glucose tolerance test nor measurement of insulin 
levels was done in the present study. Therefore, either IGT 
or hyperinsulinemia associated with increased BMI may 
be a possible explanation for the correlation between CKD 
and BMI. The independent association between CKD and 
triglyceride level in the female residents of this study appears 
to accord with this notion.
The present ﬁ  ndings are also comparable with the report 
by Tanaka and colleagues, who showed that metabolic syn-
drome is an independent, signiﬁ  cant determinant of CKD 
in a hospital−based screening program in Japan.20 In the 
present study, the differences in BMI or the percentages of 
obese subjects are relatively small between those with and 
without CKD, though BMI was extracted as a signiﬁ  cant 
factor independent of blood pressure, serum HDL, triglyc-
eride and FBG levels, which are important factors in criteria 
of metabolic syndrome. It has been thought that Asians 
including Japanese are susceptible to increased body weight 
in terms of development of metabolic disorders including 
diabetes mellitus: for example, there is a notable difference 
between the deﬁ  nition of obesity for Caucasians and that for 
Japanese.17,21 It is possible that Japanese are also susceptible 
to increased body weight in terms of development of CKD, 
but this hypothesis, as well as the detailed mechanisms of 
development of CKD associated with increased BMI, should 
be clariﬁ  ed by future studies. Recently it was reported that 
Table 2 Identiﬁ  cation of factor(s) associated with CKD by univariate and multivariate logistic analyses in male subjects
Male Univariate Multivariate
Parameters Odds ratio 95% CI Odds ratio 95% CI
Age (year) 1.048b 1.029–1.067 1.062b 1.038–1.088
BMI (Kg/m2) 1.125b 1.055–1.200 1.139b 1.055–1.230
Smokingc 0.591a 0.381–0.916 0.801 0.500–1.282
SBP (mmHg) 1.020b 1.010–1.030 0.996 0.979–1.013
DBP (mmHg) 1.027b 1.009–1.046 1.021 0.992–1.051
Antihypertensive medicinec 1.774b 1.171–2.687 1.108 0.695–1.766
Total cholesterol (mg/dl) 1.002 0.997–1.008 1.003 0.997–1.010
HDL-cholesterol (mg/dl) 0.988 0.974–1.001 0.996 0.979–1.013
Triglyceride (mg/dl) 1.001 0.999–1.004 1.002 0.999–1.004
Antidyslipidemic medicinec 1.131 0.360–3.557 0.698 0.209–2.325
FBG (mg/dl) 1.022a 1.003–1.041 1.001 0.981–1.022
Abbreviations: BMI, body mass index; SBP and DBP, systolic and diastolic blood pressure; HDL, high-density lipoprotein; FBG, fasting blood glucose. 
Notes: aP   0.05, bP   0.01, cSmoking, cAntihypertensive medicine, cAntidyslipidemic medicine, (no = 1 and yes = 2).Vascular Health and Risk Management 2009:5 320
Nomura et al
signiﬁ  cant association between CKD and BMI was found 
in men but not in women by two epidemiological studies 
done by Ishizaka and colleagues in Japan and by Shankar 
and colleagues in Singapore.22,23 The signiﬁ  cant association 
found in the females of the present study is inconsistent 
with those reports. We have no clear explanation for this 
discrepancy, while may be able to raise a possibility of dif-
ference in age of study subjects. The mean age of the female 
subjects examined by Ishizaka and colleagues was younger 
than that of the present study. Age of female subjects may 
be an important factor inﬂ  uencing results of this type of 
epidemiological study, because estrogens, blood levels of 
which decline after menopause, have been shown to exert a 
protective action on kidneys.24
Lastly, we should mention the limitations of the present 
study. First, the subjects examined in the present study were 
local residents, who had the health check-up in response to 
the recommendation of the municipal government. Therefore, 
it should be noted that the subjects examined are not neces-
sarily a group of people representative of those residing in 
the Kiyotake area in terms of basal proﬁ  les of cardiovascular 
risk factors, such as age and CKD. Next, this is a simply 
observational study examining the cross-sectional relation-
ship between BMI and CKD, and interventional, follow-up 
studies are required to see the effect of body weight reduction 
on development of CKD.
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